Global and United States Factor VIII Deficiency Treatment Market Report & Forecast 2023-2028

Report ID: 1757162 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Factor VIII Deficiency Treatment Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Factor VIII Deficiency Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Factor VIII Deficiency Treatment Market Size for the Year 2017-2028
        1.2.2 Global Factor VIII Deficiency Treatment Market Size for the Year 2017-2028
    1.3 Factor VIII Deficiency Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Factor VIII Deficiency Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Factor VIII Deficiency Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Factor VIII Deficiency Treatment Market Dynamics
        1.4.1 Factor VIII Deficiency Treatment Industry Trends
        1.4.2 Factor VIII Deficiency Treatment Market Drivers
        1.4.3 Factor VIII Deficiency Treatment Market Challenges
        1.4.4 Factor VIII Deficiency Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Factor VIII Deficiency Treatment by Type
    2.1 Factor VIII Deficiency Treatment Market Segment by Type
        2.1.1 Hemophilia A Drugs
        2.1.2 Hemophilia A Inhibitors Treatment
        2.1.3 Von Willebrand Disease Treatment
    2.2 Global Factor VIII Deficiency Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Factor VIII Deficiency Treatment Market Size by Type (2017-2028)
    2.4 United States Factor VIII Deficiency Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Factor VIII Deficiency Treatment Market Size by Type (2017-2028)
3 Factor VIII Deficiency Treatment by Application
    3.1 Factor VIII Deficiency Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Other
    3.2 Global Factor VIII Deficiency Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Factor VIII Deficiency Treatment Market Size by Application (2017-2028)
    3.4 United States Factor VIII Deficiency Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Factor VIII Deficiency Treatment Market Size by Application (2017-2028)
4 Global Factor VIII Deficiency Treatment Competitor Landscape by Company
    4.1 Global Factor VIII Deficiency Treatment Market Size by Company
        4.1.1 Top Global Factor VIII Deficiency Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Factor VIII Deficiency Treatment Revenue by Player (2017-2022)
    4.2 Global Factor VIII Deficiency Treatment Concentration Ratio (CR)
        4.2.1 Factor VIII Deficiency Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Factor VIII Deficiency Treatment in 2021
        4.2.3 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Factor VIII Deficiency Treatment Headquarters, Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Factor VIII Deficiency Treatment Headquarters and Area Served
        4.3.2 Global Factor VIII Deficiency Treatment Companies Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Factor VIII Deficiency Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Factor VIII Deficiency Treatment Market Size by Company
        4.5.1 Top Factor VIII Deficiency Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Factor VIII Deficiency Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Factor VIII Deficiency Treatment Market Size by Region
    5.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Factor VIII Deficiency Treatment Market Size by Region (2017-2028)
        5.2.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2017-2022
        5.2.2 Global Factor VIII Deficiency Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Factor VIII Deficiency Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Factor VIII Deficiency Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Factor VIII Deficiency Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Factor VIII Deficiency Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Factor VIII Deficiency Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Factor VIII Deficiency Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Factor VIII Deficiency Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Factor VIII Deficiency Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Factor VIII Deficiency Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
        7.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Takeda
        7.2.1 Takeda Company Details
        7.2.2 Takeda Business Overview
        7.2.3 Takeda Factor VIII Deficiency Treatment Introduction
        7.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.2.5 Takeda Recent Development
    7.3 Bayer HealthCare
        7.3.1 Bayer HealthCare Company Details
        7.3.2 Bayer HealthCare Business Overview
        7.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
        7.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.3.5 Bayer HealthCare Recent Development
    7.4 CSL
        7.4.1 CSL Company Details
        7.4.2 CSL Business Overview
        7.4.3 CSL Factor VIII Deficiency Treatment Introduction
        7.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.4.5 CSL Recent Development
    7.5 Grifols
        7.5.1 Grifols Company Details
        7.5.2 Grifols Business Overview
        7.5.3 Grifols Factor VIII Deficiency Treatment Introduction
        7.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.5.5 Grifols Recent Development
    7.6 Novo Nordisk
        7.6.1 Novo Nordisk Company Details
        7.6.2 Novo Nordisk Business Overview
        7.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
        7.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.6.5 Novo Nordisk Recent Development
    7.7 F. Hoffmann-La Roche
        7.7.1 F. Hoffmann-La Roche Company Details
        7.7.2 F. Hoffmann-La Roche Business Overview
        7.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
        7.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.7.5 F. Hoffmann-La Roche Recent Development
    7.8 Kedrion
        7.8.1 Kedrion Company Details
        7.8.2 Kedrion Business Overview
        7.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
        7.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.8.5 Kedrion Recent Development
    7.9 Octapharma
        7.9.1 Octapharma Company Details
        7.9.2 Octapharma Business Overview
        7.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
        7.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.9.5 Octapharma Recent Development
    7.10 Biogen Idec
        7.10.1 Biogen Idec Company Details
        7.10.2 Biogen Idec Business Overview
        7.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
        7.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.10.5 Biogen Idec Recent Development
    7.11 BioMarin Pharmaceutical
        7.11.1 BioMarin Pharmaceutical Company Details
        7.11.2 BioMarin Pharmaceutical Business Overview
        7.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
        7.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.11.5 BioMarin Pharmaceutical Recent Development
    7.12 Sangamo Therapeutics
        7.12.1 Sangamo Therapeutics Company Details
        7.12.2 Sangamo Therapeutics Business Overview
        7.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
        7.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.12.5 Sangamo Therapeutics Recent Development
    7.13 Spark Therapeutics
        7.13.1 Spark Therapeutics Company Details
        7.13.2 Spark Therapeutics Business Overview
        7.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
        7.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.13.5 Spark Therapeutics Recent Development
    7.14 Swedish Orphan Biovitrum
        7.14.1 Swedish Orphan Biovitrum Company Details
        7.14.2 Swedish Orphan Biovitrum Business Overview
        7.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
        7.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.14.5 Swedish Orphan Biovitrum Recent Development
    7.15 Uniqure NV
        7.15.1 Uniqure NV Company Details
        7.15.2 Uniqure NV Business Overview
        7.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
        7.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.15.5 Uniqure NV Recent Development
    7.16 Amarna Therapeutics
        7.16.1 Amarna Therapeutics Company Details
        7.16.2 Amarna Therapeutics Business Overview
        7.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
        7.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.16.5 Amarna Therapeutics Recent Development
    7.17 Dimension Therapeutics
        7.17.1 Dimension Therapeutics Company Details
        7.17.2 Dimension Therapeutics Business Overview
        7.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
        7.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        7.17.5 Dimension Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Factor VIII Deficiency Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Factor VIII Deficiency Treatment Market Trends
    Table 3. Factor VIII Deficiency Treatment Market Drivers
    Table 4. Factor VIII Deficiency Treatment Market Challenges
    Table 5. Factor VIII Deficiency Treatment Market Restraints
    Table 6. Global Factor VIII Deficiency Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Factor VIII Deficiency Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Factor VIII Deficiency Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Factor VIII Deficiency Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Factor VIII Deficiency Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Factor VIII Deficiency Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Factor VIII Deficiency Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Factor VIII Deficiency Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021)
    Table 15. Top Players of Factor VIII Deficiency Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Factor VIII Deficiency Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Factor VIII Deficiency Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Factor VIII Deficiency Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Factor VIII Deficiency Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Factor VIII Deficiency Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Factor VIII Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Factor VIII Deficiency Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Factor VIII Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Factor VIII Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Factor VIII Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Factor VIII Deficiency Treatment Product
    Table 33. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Takeda Company Details
    Table 36. Takeda Business Overview
    Table 37. Takeda Factor VIII Deficiency Treatment Product
    Table 38. Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 39. Takeda Recent Development
    Table 40. Bayer HealthCare Company Details
    Table 41. Bayer HealthCare Business Overview
    Table 42. Bayer HealthCare Factor VIII Deficiency Treatment Product
    Table 43. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 44. Bayer HealthCare Recent Development
    Table 45. CSL Company Details
    Table 46. CSL Business Overview
    Table 47. CSL Factor VIII Deficiency Treatment Product
    Table 48. CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 49. CSL Recent Development
    Table 50. Grifols Company Details
    Table 51. Grifols Business Overview
    Table 52. Grifols Factor VIII Deficiency Treatment Product
    Table 53. Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 54. Grifols Recent Development
    Table 55. Novo Nordisk Company Details
    Table 56. Novo Nordisk Business Overview
    Table 57. Novo Nordisk Factor VIII Deficiency Treatment Product
    Table 58. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 59. Novo Nordisk Recent Development
    Table 60. F. Hoffmann-La Roche Company Details
    Table 61. F. Hoffmann-La Roche Business Overview
    Table 62. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
    Table 63. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 64. F. Hoffmann-La Roche Recent Development
    Table 65. Kedrion Company Details
    Table 66. Kedrion Business Overview
    Table 67. Kedrion Factor VIII Deficiency Treatment Product
    Table 68. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 69. Kedrion Recent Development
    Table 70. Octapharma Company Details
    Table 71. Octapharma Business Overview
    Table 72. Octapharma Factor VIII Deficiency Treatment Product
    Table 73. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 74. Octapharma Recent Development
    Table 75. Biogen Idec Company Details
    Table 76. Biogen Idec Business Overview
    Table 77. Biogen Idec Factor VIII Deficiency Treatment Product
    Table 78. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 79. Biogen Idec Recent Development
    Table 80. BioMarin Pharmaceutical Company Details
    Table 81. BioMarin Pharmaceutical Business Overview
    Table 82. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
    Table 83. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 84. BioMarin Pharmaceutical Recent Development
    Table 85. Sangamo Therapeutics Company Details
    Table 86. Sangamo Therapeutics Business Overview
    Table 87. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
    Table 88. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 89. Sangamo Therapeutics Recent Development
    Table 90. Spark Therapeutics Company Details
    Table 91. Spark Therapeutics Business Overview
    Table 92. Spark Therapeutics Factor VIII Deficiency Treatment Product
    Table 93. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 94. Spark Therapeutics Recent Development
    Table 95. Swedish Orphan Biovitrum Company Details
    Table 96. Swedish Orphan Biovitrum Business Overview
    Table 97. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
    Table 98. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 99. Swedish Orphan Biovitrum Recent Development
    Table 100. Uniqure NV Company Details
    Table 101. Uniqure NV Business Overview
    Table 102. Uniqure NV Factor VIII Deficiency Treatment Product
    Table 103. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 104. Uniqure NV Recent Development
    Table 105. Amarna Therapeutics Company Details
    Table 106. Amarna Therapeutics Business Overview
    Table 107. Amarna Therapeutics Factor VIII Deficiency Treatment Product
    Table 108. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 109. Amarna Therapeutics Recent Development
    Table 110. Dimension Therapeutics Company Details
    Table 111. Dimension Therapeutics Business Overview
    Table 112. Dimension Therapeutics Factor VIII Deficiency Treatment Product
    Table 113. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 114. Dimension Therapeutics Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Factor VIII Deficiency Treatment Product Picture
    Figure 2. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Factor VIII Deficiency Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Factor VIII Deficiency Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Factor VIII Deficiency Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Factor VIII Deficiency Treatment Market Share in Global 2017-2028
    Figure 7. Factor VIII Deficiency Treatment Report Years Considered
    Figure 8. Product Picture of Hemophilia A Drugs
    Figure 9. Product Picture of Hemophilia A Inhibitors Treatment
    Figure 10. Product Picture of Von Willebrand Disease Treatment
    Figure 11. Global Factor VIII Deficiency Treatment Market Share by Type in 2022 & 2028
    Figure 12. Global Factor VIII Deficiency Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    Figure 14. United States Factor VIII Deficiency Treatment Market Share by Type in 2022 & 2028
    Figure 15. United States Factor VIII Deficiency Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Other
    Figure 20. Global Factor VIII Deficiency Treatment Market Share by Application in 2022 & 2028
    Figure 21. Global Factor VIII Deficiency Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    Figure 23. United States Factor VIII Deficiency Treatment Market Share by Application in 2022 & 2028
    Figure 24. United States Factor VIII Deficiency Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    Figure 26. North America Factor VIII Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Factor VIII Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Factor VIII Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Factor VIII Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Factor VIII Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Factor VIII Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 55. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 56. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 57. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 58. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 59. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 61. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 62. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 63. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 64. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 65. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 66. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 67. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 68. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 69. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 70. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics
Frequently Asked Questions
Factor VIII Deficiency Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Factor VIII Deficiency Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Factor VIII Deficiency Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Fanless PC

Fanless PC market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Farm Mechanization

Farm Mechanization market is segmented by region (country), players, by Type and by Application.  ... Read More

Fast Attack Craft

Fast Attack Craft market is segmented by region (country), players, by Type and by Application. P ... Read More